Correlation Between PsyBio Therapeutics and Edgewise Therapeutics

Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PsyBio Therapeutics Corp and Edgewise Therapeutics, you can compare the effects of market volatilities on PsyBio Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Edgewise Therapeutics.

Diversification Opportunities for PsyBio Therapeutics and Edgewise Therapeutics

0.39

Correlation Coefficient

PsyBio Therapeutics  Edgewise Therapeutics

Weak diversification

The 3 months correlation between PsyBio and Edgewise is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Edgewise Therapeutics go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Edgewise Therapeutics

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 14.03 times more return on investment than Edgewise Therapeutics. However, PsyBio Therapeutics is 14.03 times more volatile than Edgewise Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  0.01  in PsyBio Therapeutics Corp on September 23, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	99.22%
Values	Daily Returns

PsyBio Therapeutics Corp  vs.  Edgewise Therapeutics

PsyBio Therapeutics Corp

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Edgewise Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with PsyBio Therapeutics and Edgewise Therapeutics

The main advantage of trading using opposite PsyBio Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.

The idea behind PsyBio Therapeutics Corp and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.